Education
About Us
Working with TipRanks
Follow Us
Hansa Biopharma (SE:HNSA)
:HNSA
RESEARCH TOOLSreports
HNSA Analyst Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
HNSA Stock 12 Month Forecast
Average Price Target
kr143.00
▲(409.44%Upside)
| Highest Price Targetkr143.00 | Average Price Targetkr143.00 | Lowest Price Targetkr143.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
TipRanks
kr27
Hold
-3.81%
Downside
Reiterated
07/25/25
The overall stock score is primarily driven by the company's financial struggles, with significant challenges in achieving profitability and maintaining financial stability. However, positive earnings call insights and technical momentum provide some balance. The low valuation score, due to a negative P/E ratio, further impacts the stock's attractiveness.
H.C. Wainwright
kr143
Buy
409.44%
Upside
Reiterated
07/18/25
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
TipRanks
kr27
Hold
-3.81%
Downside
Reiterated
07/25/25
The overall stock score is primarily driven by the company's financial struggles, with significant challenges in achieving profitability and maintaining financial stability. However, positive earnings call insights and technical momentum provide some balance. The low valuation score, due to a negative P/E ratio, further impacts the stock's attractiveness.
H.C. Wainwright
kr143
Buy
409.44%
Upside
Reiterated
07/18/25
Best Analysts Covering Hansa Biopharma AB
1 Month
xxx
Success Rate
8/21 ratings generated profit
Average Return
-1.08%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 38.10% of your transactions generating a profit, with an average return of -1.08% per trade.
3 Months
xxx
Success Rate
8/21 ratings generated profit
Average Return
+0.54%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 38.10% of your transactions generating a profit, with an average return of +0.54% per trade.
1 Year
Success Rate
5/21 ratings generated profit
Average Return
-17.41%
reiterated a buy rating 14 days ago
Copying Douglas Tsao's trades and holding each position for 1 Year would result in 23.81% of your transactions generating a profit, with an average return of -17.41% per trade.
2 Years
xxx
Success Rate
5/21 ratings generated profit
Average Return
-22.20%
reiterated a xxx
rating 14 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 23.81% of your transactions generating a profit, with an average return of -22.20% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
HNSA Analyst Recommendation Trends
Rating
Feb 25
Apr 25
May 25
Jun 25
Jul 25
Strong Buy
4
3
2
2
2
Buy
0
0
0
0
0
Hold
0
0
2
3
5
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
4
3
4
5
7
Each month's total comprises the sum of three months' worth of ratings.
HNSA Financial Forecast
HNSA Stock Forecast FAQ
What is SE:HNSA’s average 12-month price target, according to analysts?
Based on analyst ratings, Hansa Biopharma’s 12-month average price target is 143.00.
What is SE:HNSA’s upside potential, based on the analysts’ average price target?
Hansa Biopharma has 409.44% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hansa Biopharma a Buy, Sell or Hold?
Hansa Biopharma has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Hansa Biopharma’s share price target?
The average share price target for Hansa Biopharma is 143.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is kr143.00 ,and the lowest forecast is kr143.00. The average share price target represents 409.44% Increase from the current price of kr28.07.
The highest analyst share price target is kr143.00 ,and the lowest forecast is kr143.00. The average share price target represents 409.44% Increase from the current price of kr28.07.
What do analysts say about Hansa Biopharma?
Hansa Biopharma’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
How can I buy shares of Hansa Biopharma?
To buy shares of SE:HNSA, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.